The first wealth is health.
– Ralph Waldo Emerson

Spotlight: Dr. Fernandez-Miranda

This month the PNA Spotlight focuses on Dr. Juan Carlos Fernandez-Miranda, a Professor of Neurosurgery and the Surgical Director of Brain Tumor, Skull Base and Pituitary Centers at Stanford University. Dr. Fernandez-Miranda did a neurosurgery residency at La Paz University Hospital in Madrid, Spain. He completed a fellowship in microsurgical neuroanatomy at the University of Florida. He did clinical training in cerebrovascular surgery at the University of Virginia, and in endoscopic endonasal and open skull base surgery at University of Pittsburgh Medical Center (UPMC). He joined the faculty at Stanford earlier this year. He was kind enough to answer some questions from the PNA. His answers are below:

What inspired you to choose your career path?

When I was a young kid, about 10-11 years old, I got sick with a skin rash and high fever; the family doctor visited our home, carefully examined me, and based on a number of clues, he determined I got a very rare bacterial infection known as scarlet fever; a few days of antibiotic medication and I was back to normal. I now realized that I was fascinated by the wisdom, expertise, and detective attitude of the physician, and this personal event was (I now know) key to my future decision to become a doctor.

Medical Corner: Can Prolactin Protect You?

This month the PNA Medical Corner spotlights an article co-authored by PNA member G. Edward Vates, a professor of neurosurgery at the University of Rochester. The study finds that a moderately high level of prolactin (but not excessively high level) seems to protect retinal function in patients with a tumor squeezing the optic chiasm.

Link: https://pubmed.ncbi.nlm.nih.gov/35921360/

Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas.

Affiliations expand

• PMID: 35921360 PMCID: PMC9348739 DOI: 10.1371/journal.pone.0271690

Abstract

Magnolia

Please click on image above to contact Simon Howe.

PATHFNDR

Investigational Studies to Evaluate the Safety and Efficacy of Paltusotine in Patients with Acromegaly
The PATHFNDR studies are recruiting patients to participate in clinical research for once-daily paltusotine for the treatment of acromegaly. If the studies are successful, paltusotine could be approved as a ONCE-DAILY, ORAL treatment option that gives patients an alternative to injections or twice-daily oral medications.

As a study participant, you could play an important role in advancing the options available for acromegaly treatment for yourself and many others living with this rare disease.

ABOUT THE STUDIES

The purpose of the PATHFNDR studies is to see if Crinetics Pharmaceutical's investigational medication, paltusotine, is safe and effective in patients with acromegaly.

PATHFNDR-1 is a randomized, placebo-controlled study designed to evaluate the safety and efficacy of paltusotine in
subjects with acromegaly treated with somatostatin receptor ligand (SRL) based treatment regimens. Clinicaltrials.gov

PATHFNDR-2 is a randomized, placebo-controlled study designed to evaluate the safety and efficacy of paltusotine in
subjects with non-pharmacologically treated acromegaly. Clinicaltrials.gov

See if you may qualify

1(855) 848-8486

Featured News and Updates

News Articles August 2022

Chinese Cancer Researchers Study Pituitary Hormone Receptors

The Journal Science reports that researchers with the University of Science and Technology of China “have made a breakthrough in the treatment of cancer through immunotherapy, identifying a particular hormone receptor as a potential target for the treatment.” The receptor promotes tumor growth. It is called MC5R and works with the pituitary hormone α-MSH which is produced by the pituitary gland. Read More:

Son Grows Hair, Makes a Wig for Mom with Pituitary Tumor

shahaThe Today Show’s website has the story of a man in Arizona who grew out his hair for two years in order to make a wig for his mother, who suffers from a recurring pituitary tumor. Read more:

Caption: Melanie and Matt Shaha (Courtesy Shaha family.)

Study: Signifor Reduces Tumors in Cushings

An article in Cushing’s Disease News looks at research that found that SignifActor With Acromegaly Passes Away In Los Angelesor reduced tumor size in 40% of Cushing’s patients in the study, but most of them had already had surgery. Read more:

Symptoms of a Brain Tumor

An article in VeryWellHealth lists the common signs of a brain tumor: “vomiting, seizures, balance problems, dizziness, personality changes, loss of consciousness, and more.”
Read more:

Well-Known Egyptian Acromegalic Dies at Age 27

The PNA sends its condolences to the family of Huda Abdel-Gawad, a 27-year-old acromegalic who passed away recently from kidney failure. Abdel-Gawad had come to be known as Egypt’s tallest woman. Read more:

Actor With Acromegaly Passes Away In Los Angeles

irwin keyesCharacter actor Irwin Keyes passed away recently at age 63 from complications of acromegaly. He was known for his roles in “House of 1000 Corpses”, “The Jeffersons” and “Intolerable Cruelty”.

Caption: Actor and acromegalic Irwin Keyes. (Wikimedia Commons)

Research Articles

August 2022 Research Articles

Pituitary Surgery

Free Tissue Transfer for Skull Base Osteoradionecrosis: A Novel Approach in the Endoscopic Era

Editor’s note: Dr. Kshettry is a member of the PNA.

Minimally invasive keyhole techniques for resection of giant intracranial tumors.

Risk factors for delayed postoperative hyponatremia in patients with non-functioning pituitary adenomas undergoing transsphenoidal surgery: A single-institution study.

Pituitary and COVID-19

Encephalitis due to COVID-19 in a Patient Who Has Undergone Transsphenoidal Pituitary Surgery.

Pituitary Apoplexy

Revisiting Pituitary Apoplexy.

Pituitary Tumors/Morphology

Extra-pituitary midline structural abnormalities associated with ectopic posterior pituitary detected on a new rapid MRI protocol (FAST1.2).

Ultra-High-Field 7 T Magnetic Resonance Imaging Including Dynamic and Static Contrast-Enhanced T1-Weighted Imaging Improves Detection of Secreting Pituitary Microadenomas.

Hormonal Health

Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression.

The role of prolactin/vasoinhibins in cardiovascular diseases.

Acromegaly

Second line treatment of acromegaly: Pasireotide or Pegvisomant?

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience.

Cushing’s

Pregnancy after pituitary surgery does not influence the recurrence of Cushing’s disease.

A noninvasive scoring model for the differential diagnosis of ACTH-dependent Cushing’s syndrome: a retrospective analysis of 311 patients based on easy-to-use parameters.

Copyright © 2024 Pituitary Network Association All rights reserved.

Disclaimer: PNA does not engage in the practice of medicine. It is not a medical authority, nor does it claim to have medical expertise. In all cases, PNA recommends that you consult your own physician regarding any course of treatment or medication.

Our mailing address is:
Pituitary Network Association
P.O. Box 1958
Thousand Oaks, CA 91358
(805) 499-9973 Phone - (805) 480-0633 Fax
Email [email protected]

You are receiving this Newsletter because you have shown interest in receiving information about our activities.

If you do not want to receive any more emails from PNA, Unsubscribe.